Table 4.
Quality criteria | Reference | Author’s recommendations | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[19] | [20] | [21] | [22] | [23] | [1] | [24] | [25] | [26] | [27] | [28] | [29] | [30] | [31] | [12] | [32] | |||
Selection and completeness of follow-up | Patient baseline characteristics with no/minor significant differences between FLS and no-FLS group | No | Yes | Yes | Yes | No | Yes | Yes | NR | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Participants in two groups should be carefully selected with no/minor significant differences in characteristics to avoid selection bias |
All patients were included and analyzed in both FLS and no-FLS cohorts | Yes | Yes | No | Yes | Yes | No | No | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | All patients should be included and analyzed regardless of whether they were seen in the FLS clinic | |
Inclusion/exclusion criteria are clearly described for FLS and no-FLS group | Yes | Part | Part | Part | Part | Part | Yes | Part | Yes | Part | Yes | Yes | Yes | Yes | Yes | Yes | Inclusion/exclusion criteria should be clearly described for completeness of reporting reason | |
At least 50% eligible patients attend FLS | Yes | NR | NR | NR | NR | Yes | NR | NR | NR | NR | Yes | NR | Yes | No | Yes | NR | The proportion of FLS attending is expected to be at least 50% to provide confidence of the results | |
Loss to follow-up ≤20% in FLS and no-FLS group | Yes | Yes | Part | NR | NR | NR | NR | NR | Part | NR | Yes | NR | NR | NR | Yes | NR | The loss of follow-up for both groups is expected to be less than 20% to guarantee statistical power for the results | |
Exposure | Clear description of care for FLS and no-FLS group | Yes | Part | Part | Yes | No | Part | No | Part | Part | Part | Yes | Part | Part | Part | Part | Part | Fracture care including BMD testing, treatment, education, long-term adherence, etc. should be clearly described for both groups |
Outcome | Outcomes assessed in FLS and no-FLS groups using similar method | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | The same statistical methods should be used in both groups to assess the outcomes |
Statistical accuracy and analyses | Analyses of outcomes accounted for relevant confounders | Yes | No | No | Yes | Yes | No | Yes | No | Yes | No | Yes | No | Yes | Yes | Yes | Yes | Relevant confounders should be fully adjusted using statistical models, such as multivariable cox regression model |
Sample size is based on power calculation | No | No | No | Yes | No | No | No | No | Yes | No | No | No | No | No | Yes | No | To avoid insufficient statistical power for the results, sample size should be based on power calculation | |
Analyses of outcomes account for competing risk of death | No | No | No | No | Yes | No | Yes | No | No | No | No | No | No | Yes | No | Yes | Competing risk analysis should be included in studies designed to evaluate risk of subsequent fracture | |
Total score | 7 | 5 | 3.5 | 6.5 | 4.5 | 4 | 5 | 3 | 6 | 4 | 8 | 4.5 | 5.5 | 5.5 | 8.5 | 6.5 |
Yes, fully fulfilled the criteria; No, not fulfilled the criteria; Part, partially fulfilled the criteria
NR not reported, BMD bone mineral density, FLS fracture liaison service